BLACK DIAMOND THERAPEUTICS I (BDTX) Stock Income Statement
NASDAQ:BDTX • US09203E1055
Current stock price
3.06 USD
+0.14 (+4.79%)
At close:
3.0433 USD
-0.02 (-0.55%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 70.00M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 50.13M | 78.78M | 86.46M | 92.83M | 126.87M | |||
| Research and Development | 33.56M | 51.31M | 59.35M | 64.44M | 96.83M | |||
| Selling, General, and Administrative Expenses | 16.57M | 27.47M | 27.11M | 28.39M | 30.04M | |||
| Operating Income | 19.87M | -78.78M | -86.46M | -92.83M | -126.87M | |||
| Interest Income/Expense | 4.06M | 2.18M | 1.92M | -220.00K | 3.46M | |||
| Other Income/Expense | 5.78M | 6.92M | 2.09M | -350.00K | -2.19M | |||
| Non Recurring Items | -7.35M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 22.37M | -69.68M | -82.44M | -91.17M | -125.60M | |||
| Income Tax | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Net Income | 22.37M | -69.68M | -82.44M | -91.17M | -125.60M | |||
| EBITDA | 20.20M | -78.44M | -86.02M | -92.32M | -126.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.39 | -1.27 | -1.88 | -2.51 | -3.47 | |||
| Non GAAP EPS | 0.37 | -1.27 | -1.88 | -2.52 | -3.47 | |||
| Statistics | ||||||||
| Profit Margin | 31.95% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | 28.39% | N/A | N/A | N/A | N/A | |||
All data in USD